Labena CRO & 10x Genomics: Single-Cell and Spatial Grant Challenge 2026

Cooperation terms and conditions

This document explains the general terms and conditions of the Labena Single-Cell and Spatial Grant Challenge 2026. The authors and institutions of the selected projects (participants) and Labena d.o.o. sign a cooperation agreement before the start of the experiments. These terms form the basis of that agreement.
Three projects will be selected. Each selected project receives services for one single-cell or one spatial study, as defined below.

1. How to Apply

Submit your application through the online form available at www.cro.labenagroup.com/grantchallenge by 22 November 2026. The written sections should not exceed 800 words in total.

  1.  Applicant and institution
    • Name, position, institution, country, e-mail
    • Research area
  2.  Research project
    • Research question and objectives (200 words)
    • Scientific relevance and expected impact: how will the results of your research concretely contribute to the development of your research field? (200 words)
    • How does the proposed analysis fit into your wider research? Please describe complementary methods you have already used or are planning to use, such as functional studies or validation in a larger cohort. (150 words)
    • Is this research part of a larger project with its own funding? (Yes/No. If yes, please name the funder or programme.)
  3.  Samples
    • Sample type (fresh-frozen tissue / FFPE tissue / cells / nuclei / other)
    • Number of samples
    • Preparation or fixation method (100 words)
    • Is sample quality data (e.g. DV200, viability) available? (Yes / No / Planned)
    • Date when samples will be available (no later than 31 March 2027)
  4.  Technology and experience
    • Preferred technology (Chromium / Xenium / Visium HD / Not sure yet), with an optional justification (50 words)
    • Previous experience with single-cell or spatial technologies (100 words)

Evaluation criteria

Projects are evaluated on scientific relevance, contribution to the research field, integration within the wider research project, suitability for single-cell or spatial analysis, technical feasibility, and sample readiness. We welcome both fundamental and applied research.

2. Who can apply

The Grant Challenge is open to researchers at academic and non-profit research institutions, such as universities, research institutes and university hospitals. The applicant’s institution must be based in one of the countries listed below. Eligibility depends on where the institution is located, not on the applicant’s nationality. Commercial organisations are not eligible.

EU member states: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden.

Other European countries: Albania, Andorra, Bosnia and Herzegovina, Iceland, Kosovo, Liechtenstein, Moldova, Monaco, Montenegro, North Macedonia, Norway, San Marino, Serbia, Switzerland, Türkiye, Ukraine, United Kingdom.

3. What the grant covers

Each grant covers one project on one of the following 10x Genomics platforms, as agreed with the participant.

Single-cell project (Chromium)

  • One Chromium experiment using Flex v2 (up to 16 reactions) or 3′, 5′, ATAC or Multiome chemistry (up to 4 reactions).
  • Sequencing up to a value of €2,000.
  • Standard basic bioinformatic package using Cell Ranger.

Xenium spatial project

  • Sectioning of up to 2 samples, performed by Labena’s partner laboratory.
  • One run on 10x Genomics Xenium using a pre-designed panel. Custom panels and the Xenium Prime 5K panel are not included.
  • Additional samples may be placed on the Xenium slides (imageable area approx. 2 cm² per slide). Sectioning of any additional samples is not covered by the grant and shall be covered by the participant.

Visium spatial project

  • Sectioning of up to 4 samples, performed by Labena’s partner laboratory.
  • One run on 10x Genomics Visium HD (6.5 × 6.5 mm capture area per sample).
  • Sequencing up to a value of €2,000.
  • Standard basic bioinformatic package using Space Ranger.

All projects

  • Reagents and laboratory work for the items listed above.
  • Support from Labena’s experts from study design and review of sample quality data through laboratory work to data generation.
  • Sequencing is performed in-house at Labena. If a Chromium or Visium project requires sequencing beyond the €2,000 allowance, the difference is covered by the participant.
  • An invitation to visit Labena’s laboratories in Ljubljana during the project, to see the laboratory work in person and meet the team.

4. What the grant does not cover

  • Any bioinformatic service beyond Space Ranger or Cell Ranger. It can be requested from Labena as a separate, chargeable service, or performed by the participant.
  • Custom Xenium panels and the Xenium Prime 5K panel. These are available at Labena, but their cost is not covered by the grant.
  • Sectioning of Xenium samples beyond the 2 covered by the grant.
  • Sequencing beyond the €2,000 allowance for Chromium and Visium projects.
  • Additional runs, repeat experiments, and any work beyond the agreed study design.
  • Sample material, which is provided by the participant.
  • Sample quality control (e.g. DV200 assessment), which must be performed by the participant before samples are sent to Labena.
  • Transport of samples to Labena, and any costs arising at the participant’s own institution.
  • Accommodation, travel, and subsistence expenses are not covered by the grant and shall not be reimbursed by Labena.

5. Samples and sample quality

  • See the 10x Genomics sample preparation guidelines.
  • For single-cell analysis, samples are defined as cell culture material, PBMCs, or dissociated tissues with a viability of 85% or higher. The participant ensures that samples are prepared and stored so that high-quality measurements are possible. For Flex protocols, the participant shall send fixed cells.
    In case of nuclei analysis, the participant shall have an optimized nuclei isolation protocol. The nuclei will be isolated at Labena.
  • For spatial analysis, samples are defined as fresh-frozen or FFPE tissue blocks or sections meeting the quality criteria by 10x Genomics of the selected platform.
  • Samples are assessed for quality on arrival. If samples do not meet the agreed criteria, Labena and the participant will agree on the next step, which may include the participant supplying replacement material within the project timeline. In case the participant is not able to supply replacement material within the project timeline, Labena reserves the right to award the grant to another Grant Challenge participant.
  • The participant organises transport of samples to the Molecular Biology Laboratory, Labena CRO, Labena d.o.o., Teslova ulica 30, Ljubljana, under thermal conditions that preserve the quality required for the intended measurement.
  • After the analysis is complete, remaining samples are returned to the participant or discarded, as agreed with the participant.

6. Timeline

  • Applications close on 22 November 2026.
  • Selected projects are announced on 15 December 2026.
  • Samples must be available and delivered to Labena no later than 31 March 2027.
  • Labena and the participant agree on the timeframe for the laboratory work after selection.

7. Reporting, data and confidentiality

  • The participant prepares a short report on the work carried out and submits it to Labena within one month of completion of the laboratory work. Labena keeps this information strictly confidential, unless agreed otherwise.
  • Data generated in the project is provided to the participant. The data is stored at Labena for an additional 6 months after project completion.
  • Project details, samples and results are treated as confidential by both parties until publication, except as set out in the clauses on promotion and contact data below.

8. Publication and authorship

  • Work carried out in the Grant Challenge is expected to result in a stand-alone publication or to form part of a broader scientific publication in a journal with an SCI impact factor.
  • Up to 2 Labena scientists who contribute to the laboratory work, data analysis, or writing and review of the manuscript are included as co-authors. The Labena Grant Challenge must be clearly acknowledged in the funding or acknowledgements section.
    In case of additional bioinformatic work, up to 1 more Labena scientist is included.

9. Ethics and regulatory approvals

  • If human samples are used, the participant ensures that ethics approval covers the transfer of samples or their isolates to a third party for the purposes of the analysis.
  • If laboratory animal samples are used, the participant ensures that the animal experiment was approved by the corresponding regulatory authorities, planned and performed in accordance with the 3Rs principles, and that animals were treated according to FELASA guidelines and recommendations.

10. Use of results for promotion

  • After publication, Labena may use data generated in the Grant Challenge for promotional purposes, to show the performance of the technology on real samples. The participant and their institution will be acknowledged.
  • Labena may invite the participant to take part in additional promotional activities, such as a case study, webinar or interview. Participation is voluntary, and details will be agreed with the participant beforehand.

11. Contact data

  • Contact information from the application (name, e-mail address, institution, country and area of research) is shared with 10x Genomics for marketing purposes only if the applicant has given consent on the application form. Consent is optional, does not affect the evaluation, and can be withdrawn at any time by writing to info@labena.si. Personal data is otherwise processed in accordance with Labena’s Privacy Policy available at https://cro.labenagroup.com/privacy-policy/.

12. Intellectual property

  • Both parties agree that if Labena and the participant’s organisation jointly develop a commercial kit or service based on the project, intellectual property rights will be owned by both parties in proportion to the resources invested (equipment, infrastructure, financial). A separate agreement will be signed for this purpose.
  • Results generated from the participant’s own samples remain the property of the participant and their institution.